I71.4
Conditions
Interventions
Group 1: Blood samples from patients with abdominal aortic aneurysm > 5 cm
Group 2: Blood samples from patients without an abdominal aortic aneurysm
Sponsors
Klinik für Gefäßchirurgie und Endovaskuläre Chirurgie, Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Capacity to consent Patients = 18 years with abdominal aortic aneurysm (max diameter > 3 cm). Patients = 18 years of age with dilated aorta (precursors of AAA, max diameter 2-3 cm) Subjects with demonstrably undilated aorta (sonographic or MR-graphic or CT-graphic evidence). For all patients and subjects: Informed consent for the study: "Establishment of a human vascular biomaterial bank (VBBH) at the Department of Vascular Surgery and Endovascular Surgery at Heidelberg University Hospital" (professional advice of 23.09.2013 and subsequent amendment of 18.09.2020 to S-301/2013).
Exclusion criteria
Exclusion criteria: Refusal or lack of consent of the donor to participate in the above mentioned VBBH tissue bank study. Lack of consent of the donor for the use of his tissue for research purposes Patients permanently incapable of giving consent Pregnant and breastfeeding women Patients/proband with malignant or chronic inflammatory disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this study is to identify circulating biomolecules in blood plasma that correlate with AAA disease progression | — |
Countries
Germany
Contacts
Public ContactKarola Passek
Klinik für Gefäßchirurgie und Endovaskuläre Chirurgie, Universitätsklinikum Heidelberg
Outcome results
None listed